Cardiometabolic Comorbidities in Cancer Survivors:
ACE, angiotensin-converting enzyme
ARB, angiotensin receptor blocker
CVD, cardiovascular disease
LDL-C, low-density lipoprotein cholesterol
cancer survivorship
cardiovascular comorbidities
coordination of care
medication adherence
multidisciplinary care
Journal
JACC. CardioOncology
ISSN: 2666-0873
Titre abrégé: JACC CardioOncol
Pays: United States
ID NLM: 101761697
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
19
09
2021
revised:
16
03
2022
accepted:
18
03
2022
entrez:
12
7
2022
pubmed:
13
7
2022
medline:
13
7
2022
Statut:
epublish
Résumé
There are nearly 17 million cancer survivors in the United States, including those who are currently receiving cancer therapy with curative intent and expected to be long-term survivors, as well as those with chronic cancers such as metastatic disease or chronic lymphocytic leukemia, who will receive cancer therapy for many years. Current clinical practice guidelines focus on lifestyle interventions, such as exercise and healthy eating habits, but generally do not address management strategies for clinicians or strategies to increase adherence to medications. We discuss 3 cardiometabolic comorbidities among cancer survivors and present the prevalence of comorbidities prior to a cancer diagnosis, treatment of comorbidities during cancer therapy, and management considerations of comorbidities in long-term cancer survivors or those on chronic cancer therapy. Approaches to support medication adherence and potential methods to enhance a team approach to optimize care of the individual with cancer across the continuum of disease are discussed.
Identifiants
pubmed: 35818559
doi: 10.1016/j.jaccao.2022.03.005
pii: S2666-0873(22)00219-8
pmc: PMC9270612
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
149-165Déclaration de conflit d'intérêts
This work was supported by a grant from the National Cancer Institute (CA249568; MPI Drs Oeffinger and Zullig). Dr Zullig has received research funding from Proteus Digital Health and the PhRMA Foundation; and consulting fees from Novartis and Pfizer. Dr Sung has received research grants from Merck and Novartis; and research supplies from DSM and Clasado. Dr Blalock has served as a consultant for the Eating Recovery Center. Dr Bosworth has received research grants from the PhRMA Foundation, Proteus Digital Health, Otsuka, Novo Nordisk, Sanofi, and Improved Patient Outcomes; and consulting fees from Sanofi, Novartis, Otsuka, Abbott, Preventric Diagnostics, and the Medicines Company. Dr Oeffinger has served as a consultant for GRAIL. Dr Dent has received honoraria and grant funding from Novartis. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Références
Cancer Med. 2018 Dec;7(12):6331-6339
pubmed: 30358141
Ann Oncol. 2017 Dec 01;28(12):2932-2942
pubmed: 28950290
Cancer Manag Res. 2019 Jul 22;11:6793-6802
pubmed: 31413631
BMC Cancer. 2015 Jan 31;15:28
pubmed: 25637285
J Clin Endocrinol Metab. 2018 Sep 1;103(9):3144-3154
pubmed: 29955867
Ann Hematol. 1999 Jul;78(7):315-9
pubmed: 10466443
Ann Intern Med. 2004 Sep 21;141(6):421-31
pubmed: 15381515
MMWR Morb Mortal Wkly Rep. 2017 Nov 17;66(45):1248-1251
pubmed: 29145353
JAMA. 2011 Dec 7;306(21):2359-66
pubmed: 22147380
Eur J Prev Cardiol. 2021 Jul 23;28(8):864-872
pubmed: 34298552
PLoS One. 2012;7(6):e39445
pubmed: 22761797
J Clin Oncol. 2022 May 20;40(15):1635-1646
pubmed: 35025627
J Geriatr Oncol. 2021 Jan;12(1):72-79
pubmed: 32423699
Cancer. 2000 Feb 1;88(3):653-63
pubmed: 10649261
J Clin Oncol. 2016 Apr 1;34(10):1122-30
pubmed: 26834065
BMJ Open. 2017 Feb 10;7(2):e013496
pubmed: 28188154
JAMA Netw Open. 2019 Aug 2;2(8):e198890
pubmed: 31397860
Med Sci Sports Exerc. 2010 Jul;42(7):1409-26
pubmed: 20559064
Clin Breast Cancer. 2018 Apr;18(2):175-183
pubmed: 29598955
PLoS One. 2012;7(1):e29849
pubmed: 22276132
Breast Cancer Res Treat. 2018 Jul;170(1):119-127
pubmed: 29492735
Oncotarget. 2016 Jul 5;7(27):42208-42215
pubmed: 27283991
J Clin Oncol. 2010 Oct 10;28(29):e560-1; author reply e562
pubmed: 20805462
N Engl J Med. 2012 Jul 12;367(2):107-14
pubmed: 22663011
N Engl J Med. 2007 Oct 11;357(15):1477-86
pubmed: 17928595
Semin Oncol. 2013 Dec;40(6):690-708
pubmed: 24331191
Br J Clin Pharmacol. 2012 May;73(5):691-705
pubmed: 22486599
N Engl J Med. 2004 Jun 3;350(23):2335-42
pubmed: 15175435
JAMA. 2014 Feb 5;311(5):507-20
pubmed: 24352797
J Clin Oncol. 2016 May 10;34(14):1626-33
pubmed: 26951318
Haematologica. 2011 Jan;96(1):150-5
pubmed: 20851864
Cochrane Database Syst Rev. 2018 Sep 19;9:CD010192
pubmed: 30229557
BMJ Case Rep. 2012 Feb 25;2012:
pubmed: 22665559
Circulation. 2016 Mar 15;133(11):1073-80
pubmed: 26864092
J Clin Oncol. 2012 Dec 20;30(36):4458-61
pubmed: 23045598
Ann Intern Med. 2017 Mar 21;166(6):430-437
pubmed: 28135725
Tex Heart Inst J. 2011;38(3):263-5
pubmed: 21720467
Diabetologia. 2014 May;57(5):927-34
pubmed: 24633676
BMC Fam Pract. 2021 Nov 18;22(1):234
pubmed: 34794388
Diabet Med. 2021 Jun;38(6):e14538
pubmed: 33548062
Breast Cancer Res Treat. 2017 Nov;166(2):541-547
pubmed: 28801846
J Clin Oncol. 2013 Nov 20;31(33):4222-8
pubmed: 24127446
Lancet. 1971 Jul 24;2(7717):203-6
pubmed: 21090384
Cancer. 2014 May 1;120(9):1290-314
pubmed: 24343171
Free Radic Biol Med. 2005 Aug 1;39(3):412-25
pubmed: 15993340
ESMO Open. 2021 Aug;6(4):100218
pubmed: 34303930
Lipids Health Dis. 2015 Nov 02;14:140
pubmed: 26526340
Lancet. 1998 Sep 12;352(9131):837-53
pubmed: 9742976
J Natl Cancer Inst. 2010 Jan 6;102(1):39-46
pubmed: 19996060
J Clin Oncol. 2009 Jul 20;27(21):3452-8
pubmed: 19506162
Curr Oncol. 2013 Dec;20(6):e532-8
pubmed: 24311953
Cancer. 2015 Dec 1;121(23):4212-21
pubmed: 26624564
Breast Cancer Res Treat. 2017 Jan;161(1):161-172
pubmed: 27826756
N Engl J Med. 1996 Oct 3;335(14):1001-9
pubmed: 8801446
J Clin Oncol. 2009 Dec 20;27(36):6152-9
pubmed: 19901116
Clin Hypertens. 2019 Apr 01;25:5
pubmed: 30984412
Ann Oncol. 2020 Aug;31(8):1001-1010
pubmed: 32416251
JACC CardioOncol. 2020 Sep 15;2(3):363-378
pubmed: 34396245
Semin Oncol. 2013 Dec;40(6):804-12
pubmed: 24331199
Blood. 2018 Jul 26;132(4):393-404
pubmed: 29567798
J Clin Oncol. 2017 Mar 10;35(8):893-911
pubmed: 27918725
Pharmacoepidemiol Drug Saf. 2016 Aug;25(8):898-907
pubmed: 26875432
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
JAMA. 1996 Jan 3;275(1):67-9
pubmed: 8531290
Curr Oncol. 2017 Apr;24(2):75-80
pubmed: 28490920
J Clin Oncol. 2017 Dec 1;35(34):3837-3843
pubmed: 28922087
N Engl J Med. 2008 Mar 13;358(11):1129-36
pubmed: 18337603
Endocrinol Metab (Seoul). 2017 Mar;32(1):23-29
pubmed: 28345313
Cancer. 2022 Feb 15;128(4):828-838
pubmed: 34706057
Breast Cancer Res. 2018 Nov 20;20(1):144
pubmed: 30458856
JAMA. 2016 Sep 27;316(12):1289-97
pubmed: 27673306
J Clin Oncol. 2016 Nov 10;34(32):3906-3913
pubmed: 27621394
Br J Clin Pharmacol. 2020 Apr;86(4):734-744
pubmed: 31721271
Oncogene. 2017 Nov 16;36(46):6462-6471
pubmed: 28759039
J Natl Cancer Inst. 2010 May 5;102(9):596-604
pubmed: 20351338
BMC Cancer. 2019 Mar 27;19(1):270
pubmed: 30917783
JAMA. 1981 Jan 16;245(3):247-52
pubmed: 7452849
JAMA. 2006 Jan 4;295(1):74-80
pubmed: 16391219
N Engl J Med. 2008 Jun 12;358(24):2545-59
pubmed: 18539917
CA Cancer J Clin. 2019 Sep;69(5):363-385
pubmed: 31184787
J Clin Oncol. 2008 Dec 1;26(34):5537-43
pubmed: 18809605
Patient Educ Couns. 2020 Oct;103(10):2132-2141
pubmed: 32402488
J Cancer Surviv. 2015 Dec;9(4):641-9
pubmed: 25716644
Breast Cancer Res Treat. 2017 Apr;162(3):549-557
pubmed: 28176174
Clin Colorectal Cancer. 2011 Sep;10(3):151-6
pubmed: 21855035
Diabetes Res Clin Pract. 2018 May;139:323-330
pubmed: 29526679
Circulation. 2015 Jan 27;131(4):e29-322
pubmed: 25520374
Eur Heart J. 2016 Sep 21;37(36):2768-2801
pubmed: 27567406
Ann Intern Med. 2021 Nov;174(11):1528-1541
pubmed: 34570599
Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):123-33
pubmed: 21051654
Fam Med. 2013 Jul-Aug;45(7):463-74
pubmed: 23846965
J Am Coll Cardiol. 2019 Jun 25;73(24):e285-e350
pubmed: 30423393
BMC Endocr Disord. 2019 Jun 11;19(1):60
pubmed: 31185995
Br J Cancer. 2018 Aug;119(4):408-418
pubmed: 30065254
J Cancer Epidemiol. 2012;2012:206414
pubmed: 22956953
Diabetologia. 2015 May;58(5):951-60
pubmed: 25638246
BMC Cancer. 2018 Jun 15;18(1):654
pubmed: 29902993
J Clin Oncol. 2016 Oct 20;34(30):3664-3671
pubmed: 27601537
N Engl J Med. 2012 Nov 8;367(19):1792-802
pubmed: 23134381
J Urol. 2018 Aug;200(2):335-343
pubmed: 29534997
Cancer Invest. 2011 Nov;29(9):585-93
pubmed: 21936625
Hypertension. 2020 Jun;75(6):1334-1357
pubmed: 32370572
JAMA. 1987 Feb 20;257(7):943-8
pubmed: 3806876
Oncologist. 2016 Nov;21(11):1326-1336
pubmed: 27473045
J Cancer Surviv. 2013 Jun;7(2):253-61
pubmed: 23417882
Am J Pathol. 2011 Jan;178(1):402-12
pubmed: 21224077
Clin Cancer Res. 2008 May 15;14(10):3124-31
pubmed: 18483380
JAMA. 2008 Dec 17;300(23):2754-64
pubmed: 19088353
J Cancer Surviv. 2018 Dec;12(6):794-802
pubmed: 30338462
J Oncol Pract. 2016 Aug;12(8):e800-9
pubmed: 27407167
J Clin Oncol. 2012 Jul 10;30(20):2530-7
pubmed: 22614980
Biol Chem. 2015 Jan;396(1):1-11
pubmed: 25205720
Lancet. 2002 Nov 23;360(9346):1623-30
pubmed: 12457784
Med Sci Sports Exerc. 2003 Nov;35(11):1846-52
pubmed: 14600549
Breast Cancer Res Treat. 2017 Aug;164(3):537-555
pubmed: 28503723
Blood. 2012 Nov 29;120(23):4505-12
pubmed: 23034279
Can J Cardiol. 2016 Jul;32(7):852-62
pubmed: 26968393
JAMA. 1990 Apr 18;263(15):2083-5
pubmed: 2319669
J Allergy Clin Immunol Pract. 2016 Sep-Oct;4(5):802-12
pubmed: 27587314
Cardiovasc Toxicol. 2019 Aug;19(4):382-387
pubmed: 30543051
J Am Coll Cardiol. 2018 May 15;71(19):e127-e248
pubmed: 29146535
Am J Cancer Res. 2019 Feb 01;9(2):219-227
pubmed: 30906624
Breast Cancer Res Treat. 2013 Feb;138(1):225-33
pubmed: 23358904
Clin Diabetes. 2019 Jan;37(1):11-34
pubmed: 30705493
Curr Opin Pharmacol. 2012 Dec;12(6):751-9
pubmed: 22824430
Blood Press. 2020 Dec;29(6):339-340
pubmed: 32985929
Lancet. 2014 Mar 22;383(9922):1041-8
pubmed: 24333009
Blood Adv. 2018 Jul 24;2(14):1756-1764
pubmed: 30037802
Epidemiology. 2016 Jan;27(1):6-13
pubmed: 26414938
J Oncol Pract. 2015 Nov;11(6):429-34
pubmed: 26105669
JACC CardioOncol. 2019 Dec;1(2):238-251
pubmed: 32206762
Cancer Med. 2018 Dec;7(12):6084-6092
pubmed: 30453386
N Engl J Med. 2009 Jan 8;360(2):129-39
pubmed: 19092145
Ann Oncol. 2007 Jun;18(6):1117
pubmed: 17586751
Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1029-36
pubmed: 27371756
J Natl Compr Canc Netw. 2021 Mar 10;19(6):709-718
pubmed: 34129522
J Comorb. 2014 Aug 18;4:29-36
pubmed: 29090151
Clin J Oncol Nurs. 2011 Feb;15(1):E3-12
pubmed: 21278033
Cancer Treat Rev. 2017 Sep;59:123-131
pubmed: 28818671
J Natl Compr Canc Netw. 2014 Jan;12(1):34-45
pubmed: 24453291
Circulation. 2020 Feb 18;141(7):549-559
pubmed: 32065766
Am Fam Physician. 2014 Oct 1;90(7):503-4
pubmed: 25369633
J Clin Oncol. 2007 Sep 1;25(25):3808-15
pubmed: 17664460
J Gen Intern Med. 2009 Sep;24(9):1029-36
pubmed: 19597893
Clin Breast Cancer. 2017 Feb;17(1):11-17
pubmed: 27561703
Health Care Financ Rev. 2008 Summer;29(4):41-56
pubmed: 18773613
JAMA Oncol. 2018 Feb 01;4(2):173-182
pubmed: 28973656
J Am Coll Cardiol. 2012 Dec 18;60(24):2504-12
pubmed: 23158536
Horm Res Paediatr. 2019;91(2):118-127
pubmed: 30650414
Am J Med. 2010 Jan;123(1):87.e1-6
pubmed: 20102997
Blood. 2007 Feb 15;109(4):1765-72
pubmed: 17047152
Cancer Epidemiol. 2017 Dec;51:62-67
pubmed: 29049937
Endocrine. 2017 Apr;56(1):90-97
pubmed: 28058528
Circulation. 2017 Mar 7;135(10):e146-e603
pubmed: 28122885
N Engl J Med. 2008 Jun 12;358(24):2560-72
pubmed: 18539916
JAMA Oncol. 2016 Dec 01;2(12):1590-1597
pubmed: 27100398
JAMA. 1998 May 27;279(20):1615-22
pubmed: 9613910
J Clin Oncol. 2006 Nov 10;24(32):5117-24
pubmed: 17093273
Circulation. 2019 May 21;139(21):e997-e1012
pubmed: 30955352
N Engl J Med. 2013 Mar 14;368(11):987-98
pubmed: 23484825
Ageing Res Rev. 2016 Mar;26:96-111
pubmed: 26835847
Am Heart J. 2011 Sep;162(3):412-24
pubmed: 21884856